Synergetics USA (NASDAQ: SURG) and ABIOMED (NASDAQ:ABMD) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Insider and Institutional Ownership

89.7% of ABIOMED shares are owned by institutional investors. 7.0% of ABIOMED shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.


This table compares Synergetics USA and ABIOMED’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Synergetics USA 7.35% 9.09% 6.45%
ABIOMED 16.13% 13.03% 10.98%

Analyst Ratings

This is a summary of current recommendations and price targets for Synergetics USA and ABIOMED, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synergetics USA 0 0 0 0 N/A
ABIOMED 0 1 7 0 2.88

ABIOMED has a consensus target price of $167.57, suggesting a potential downside of 3.69%. Given ABIOMED’s higher possible upside, analysts clearly believe ABIOMED is more favorable than Synergetics USA.

Valuation and Earnings

This table compares Synergetics USA and ABIOMED’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Synergetics USA N/A N/A N/A N/A N/A
ABIOMED $474.78 million 16.16 $110.92 million $1.69 102.96

ABIOMED has higher revenue and earnings than Synergetics USA.


ABIOMED beats Synergetics USA on 8 of the 8 factors compared between the two stocks.

Synergetics USA Company Profile

Synergetics USA, Inc., formerly Valley Forge Scientific Corp., is a supplier of precision surgical devices. The Company focuses on the surgical disciplines of ophthalmology and neurosurgery. It offers precision engineered disposable and reusable devices, surgical equipment and surgical procedural kits. It also delivers energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, visible light energy for illumination and simultaneous infusion (irrigation) of fluids into the operative field. Its products include VersaVIT 2.0 Vitrectomy System, Directional II Laser Probe and Pinnacle 360°. It offers its products under the brand names: VersaPACK, Core Essentials, Photon, Solitaire, Volk’s and Labtician’s, among others. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market. It sells its products in approximately 60 countries outside the United States.

ABIOMED Company Profile

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company’s product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company’s products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Receive News & Ratings for Synergetics USA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergetics USA Inc and related companies with's FREE daily email newsletter.